Risultati della ricerca - Jonathan Goldin
- Mostra 1 - 20 risultati su 54
- Vai alla pagina seguente
-
1
Imaging Lung Disease in Systemic Sclerosis di Diane C. Strollo, Jonathan Goldin
Pubblicazione 2010Revisão -
2
-
3
<p>Transition from Restrictive to Obstructive Lung Function Impairment During Treatment and Follow-Up of Active Tuberculosis</p> di Brian Allwood, Elizna Maasdorp, Grace J. Kim, Christopher B. Cooper, Jonathan Goldin, Richard N. van Zyl-Smit, Eric Bateman, Rodney Dawson
Pubblicazione 2020Artigo -
4
-
5
-
6
A method for the automatic quantification of the completeness of pulmonary fissures: evaluation in a database of subjects with severe emphysema di Eva M. van Rikxoort, Jonathan Goldin, Maya Galperin-Aizenberg, Fereidoun Abtin, Hyun J. Kim, Peiyun Lu, Bram van Ginneken, Greg Shaw, Matthew S. Brown
Pubblicazione 2011Artigo -
7
-
8
High-Resolution Chest CT Findings Do Not Predict the Presence of Pulmonary Hypertension in Advanced Idiopathic Pulmonary Fibrosis di David A. Zisman, Arun S. Karlamangla, David J. Ross, Michael P. Keane, John A. Belperio, Rajan Saggar, Joseph P. Lynch, A. Ardehali, Jonathan Goldin
Pubblicazione 2007Artigo -
9
Classification of Parenchymal Abnormality in Scleroderma Lung Using a Novel Approach to Denoise Images Collected via a Multicenter Study di Hyun J. Kim, Gang Li, David W. Gjertson, Robert M. Elashoff, Sumit K. Shah, Robert Ochs, Fah Vasunilashorn, Fereidoun Abtin, Matthew S. Brown, Jonathan Goldin
Pubblicazione 2008Artigo -
10
Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction di Charlie Strange, Felix J.F. Herth, Kevin L. Kovitz, Geoffrey McLennan, Armin Ernst, Jonathan Goldin, Marc Noppen, Gerard J. Criner, Frank C. Sciurba
Pubblicazione 2007Artigo -
11
-
12
Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone di Melanie Kappadakunnel, Ascia Eskin, Jun Dong, Stanley F. Nelson, Paul S. Mischel, Linda M. Liau, Phioanh Ngheimphu, Albert Lai, Timothy F. Cloughesy, Jonathan Goldin, Whitney B. Pope
Pubblicazione 2009Artigo -
13
Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung... di Elizabeth R. Volkmann, Donald P. Tashkin, Holly LeClair, Michael D. Roth, Grace Hyun J. Kim, Jonathan Goldin, Philip J. Clements, Daniel E. Furst, Dinesh Khanna
Pubblicazione 2020Artigo -
14
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis–Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial di Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, Bridget K. Wagner, Mauro Zucchetto, Ganesh Raghu, Fernando J. Martínez, Jonathan Goldin, Jeffrey Siegel, Christopher P. Denton
Pubblicazione 2021Artigo -
15
-
16
Predicting treatment outcomes and responder subsets in scleroderma‐related interstitial lung disease di Michael D. Roth, Chi‐Hong Tseng, Philip J. Clements, Daniel E. Fürst, Donald P. Tashkin, Jonathan Goldin, Dinesh Khanna, Eric C. Kleerup, Ning Li, David Elashoff, Robert M. Elashoff
Pubblicazione 2011Artigo -
17
Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II di Jonathan Goldin, Grace Hyun J. Kim, Chi‐Hong Tseng, Elizabeth R. Volkmann, Daniel E. Fürst, Philip J. Clements, Matthew A. Brown, Michael D. Roth, Dinesh Khanna, Donald P. Tashkin
Pubblicazione 2018Artigo -
18
A Dose-Ranging Study of Cabozantinib in Men with Castration-Resistant Prostate Cancer and Bone Metastases di Richard J. Lee, Philip J. Saylor, M. Dror Michaelson, S. Michael Rothenberg, Malgorzata E. Smas, David T. Miyamoto, Carol Gurski, Wanling Xie, Shyamala Maheswaran, Daniel A. Haber, Jonathan Goldin, Matthew R. Smith
Pubblicazione 2013Artigo -
19
Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis di William G. Goodman, Jonathan Goldin, Beatriz D. Kuizon, Chun Yoon, Barbara Gales, Donna Sider, Yan Wang, Joanie Chung, Aletha M. Emerick, Lloyd E. Greaser, Robert M. Elashoff, Isidro B. Salusky
Pubblicazione 2000Artigo -
20
Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis–Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II di Elizabeth R. Volkmann, Donald P. Tashkin, Ning Li, Michael D. Roth, Dinesh Khanna, Anna‐Maria Hoffmann‐Vold, Grace Kim, Jonathan Goldin, Philip J. Clements, Daniel E. Furst, Robert M. Elashoff
Pubblicazione 2017Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Internal medicine
Lung
Pathology
Interstitial lung disease
Radiology
Inoculation
Scleroderma (fungus)
Gastroenterology
Alternative medicine
Diffusing capacity
Lung function
Pulmonary function testing
Chemotherapy
Placebo
Cardiology
Surgery
Vital capacity
Cyclophosphamide
Disease
High-resolution computed tomography
Randomized controlled trial
Pulmonary fibrosis
Clinical endpoint
Clinical trial
DLCO
Nuclear medicine
Artificial intelligence
Biology
Cancer